Sangju Ganmao Tablet
Natural health product licensed in Canada
- Other names
- Mulberry Leaf and Chrysanthemum Cold Tablet, Sangju Ganmao Pian
- Licence holder
- SmartPEP (Canada) Biological Technology Research Ltd.
- NPN or DIN-HM
- 80080092
- Status
- Active licence
- Licence date
- 18 September 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Platycodon grandiflorus (Jacq.) A.DC.: L'étiquetage doit comporter un avertissement déconseillant un usage prolongé, tel que "L'usage prolongé peut irriter l'estomac".
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phragmites australis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 12.803:1 Dry plant equivalent : 370 milligramme | 28.9 milligramme | Not calculated |
| Morus alba Source : Feuille Extract : Matériel brut sec Extraction ratio : 12.803:1 Dry plant equivalent : 465 milligramme | 36.32 milligramme | Not calculated |
| Glycyrrhiza uralensis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 12.799:1 Dry plant equivalent : 150 milligramme | 11.72 milligramme | Not calculated |
| Glycyrrhiza uralensis Source : Racine Extract : Matériel brut sec Extraction ratio : 12.799:1 Dry plant equivalent : 150 milligramme | 11.72 milligramme | Not calculated |
| Chrysanthemum x morifolium Source : Fleur Extract : Matériel brut sec Extraction ratio : 12.803:1 Dry plant equivalent : 185 milligramme | 14.45 milligramme | Not calculated |
| Forsythia suspensa Source : Fruit Extract : Matériel brut sec Extraction ratio : 12.803:1 Dry plant equivalent : 280 milligramme | 21.87 milligramme | Not calculated |
| Mentha canadensis Source : Feuille | 1 milligramme | Not calculated |
| Prunus armeniaca Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 12.803:1 Dry plant equivalent : 370 milligramme | 28.9 milligramme | Not calculated |
| Platycodon grandiflorus Source : Racine | 370 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 4 Comprimé ; maximum: 8 Comprimé | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Remedy based on the theory of Traditional Chinese Medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. If you have a liver disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80080092
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.